From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials
BioProcessing Journal · 2026-07-27 · 6
DOI: 10.12665/j72.kcarson ↗At a glance
Journal article in BioProcessing Journal, published online on 2026-07-27. Written by Keith L. Carson.
Abstract (original language)
There are many examples of efforts to make biosimilar products, such as every time a product is taken to a larger scale, and when an established product is transferred to another facility, including a contract manufacturing site. While most of these examples have resulted in products which were indistinguishable for all practical purposes, others revealed troubling differences during product characterization or clinical administration...
Cite
APA
Carson, K. L. (2026). From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials. BioProcessing Journal, 6. https://doi.org/10.12665/j72.kcarson
Vancouver
Carson KL. From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials. BioProcessing Journal. 2026:6. doi:10.12665/j72.kcarson
BibTeX
@article{Carson2026,
author = {Carson, Keith L.},
title = {From the Publisher: Biosimilars, Biogenerics, or Follow-On Biologics to Licensed Materials},
journal = {BioProcessing Journal},
year = {2026},
pages = {6},
doi = {10.12665/j72.kcarson}
}
EUVIMED